Tübingen High Altitude Ophthalmology Study

NCT01245114 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2010-12-03

No results posted yet for this study

Summary

Tuebingen High Altitude Ophthalmology Study to investigate the effects of high altitude on retinal structure and function as well as anterior chamber in regard to acute mountain sickness.

Conditions

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Florian Gekeler, MD · Eye Hospital, University of Tübingen, Germany

  • Gabriel Willmann, MD · Eye Hospital, University of Tübingen, Germany

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Completion
2010-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01245114 on ClinicalTrials.gov